Department of Oncology, National Resource Center for Late Effects after Cancer Treatment, Oslo University Hospital, N-0424 Oslo, Norway.
Faculty of Medicine, University of Oslo, N-0318 Oslo, Norway.
Curr Oncol. 2022 Aug 17;29(8):5823-5832. doi: 10.3390/curroncol29080459.
The personality trait of neuroticism is associated with adverse health outcomes after cancer treatment, but few studies concern men treated for prostate cancer. We examined men with high and low neuroticism treated with radical prostatectomy for curable prostate cancer without relapse. We compared overall problems and domain summary scores (DSSs) between these groups, and if high neuroticism at pre-treatment was a significant predictor of overall problems and DSSs at follow-up. A sample of 462 relapse-free Norwegian men self-rated neuroticism, overall problems, and DSSs by the EPIC-26 before surgery and at three years' follow-up. Twenty-one percent of the sample had high neuroticism. Patients with high neuroticism reported significantly more overall problems and DSSs at pre-treatment. At follow-up, only overall bowel problems and urinary irritation/obstruction and bowel DSSs were different. High neuroticism was a significant predictor of overall bowel problems and bowel and irritation/obstruction DSSs at follow-up. High neuroticism at pre-treatment was significantly associated with a higher rate of overall problems both at pre-treatment and follow-up and had some significant predictions concerning bowel problems and urinary obstruction at follow-up. Screening for neuroticism at pre-treatment could identify patients in need of more counseling concerning later adverse health outcomes.
神经质人格特质与癌症治疗后不良健康结果相关,但针对接受前列腺癌治疗的男性的研究较少。我们研究了接受根治性前列腺切除术治疗无复发可治愈前列腺癌的高神经质和低神经质男性。我们比较了这些组之间的总体问题和领域总结评分(DSS),以及治疗前的高神经质是否是随访时总体问题和 DSS 的显著预测因素。一个由 462 名无复发的挪威男性组成的样本在手术前和三年随访时通过 EPIC-26 自我评估神经质、总体问题和 DSS。21%的样本具有高神经质。治疗前,神经质较高的患者报告的总体问题和 DSS 明显更多。在随访时,只有总体肠道问题以及尿刺激/梗阻和肠道 DSS 不同。治疗前的高神经质是随访时总体肠道问题和肠道以及刺激/梗阻 DSS 的显著预测因素。治疗前的高神经质与治疗前和随访时的总体问题发生率较高显著相关,并对随访时的肠道问题和尿梗阻有一些显著预测。在治疗前进行神经质筛查可以识别出需要更多咨询以了解后期不良健康结果的患者。